| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 4.51e-07 | 4 | 6 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.29e-03 | 188 | 6 | 2 | GO:0005201 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.42e-08 | 109 | 7 | 4 | GO:0005796 | |
| Domain | SEA | 6.90e-12 | 14 | 7 | 4 | SM00200 | |
| Domain | SEA_dom | 6.10e-11 | 23 | 7 | 4 | IPR000082 | |
| Domain | SEA | 6.10e-11 | 23 | 7 | 4 | PS50024 | |
| Domain | SEA | 4.95e-08 | 22 | 7 | 3 | PF01390 | |
| Domain | - | 1.26e-05 | 15 | 7 | 2 | 3.30.70.960 | |
| Domain | EGF | 6.63e-05 | 235 | 7 | 3 | SM00181 | |
| Domain | EGF_3 | 6.63e-05 | 235 | 7 | 3 | PS50026 | |
| Domain | EGF-like_dom | 7.88e-05 | 249 | 7 | 3 | IPR000742 | |
| Domain | EGF_1 | 8.45e-05 | 255 | 7 | 3 | PS00022 | |
| Domain | EGF-like_CS | 9.06e-05 | 261 | 7 | 3 | IPR013032 | |
| Domain | EGF_2 | 9.48e-05 | 265 | 7 | 3 | PS01186 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.39e-08 | 16 | 6 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.91e-08 | 17 | 6 | 3 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 7.56e-08 | 23 | 6 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.11e-07 | 26 | 6 | 3 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.61e-06 | 62 | 6 | 3 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.12e-06 | 68 | 6 | 3 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.34e-06 | 111 | 6 | 3 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.88e-05 | 140 | 6 | 3 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.00e-05 | 143 | 6 | 3 | M27275 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.16e-05 | 21 | 6 | 2 | MM15706 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.06e-04 | 250 | 6 | 3 | M27554 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.64e-04 | 60 | 6 | 2 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 8.71e-04 | 109 | 6 | 2 | MM15164 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 8.50e-03 | 1128 | 6 | 3 | M1036 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 1.79e-02 | 1475 | 6 | 3 | M19806 | |
| Pubmed | 4.99e-12 | 3 | 7 | 3 | 10512748 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 4.07e-09 | 18 | 7 | 3 | 18834073 | |
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 12958310 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 3.47e-08 | 2 | 7 | 2 | 2393399 | |
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 9334251 | ||
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 11289722 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 3.47e-08 | 2 | 7 | 2 | 10973822 | |
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 3.47e-08 | 2 | 7 | 2 | 10405327 | |
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 1.04e-07 | 3 | 7 | 2 | 18163520 | |
| Pubmed | 6.82e-05 | 441 | 7 | 3 | 12853948 | ||
| Cytoband | 7q22 | 1.40e-05 | 38 | 7 | 2 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 4.68e-04 | 219 | 7 | 2 | chr7q22 | |
| GeneFamily | CD molecules|Mucins | 6.72e-12 | 21 | 5 | 4 | 648 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.28e-06 | 170 | 6 | 3 | M5880 | |
| Coexpression | DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS | 2.01e-04 | 97 | 6 | 2 | M40301 | |
| Coexpression | XU_GH1_EXOGENOUS_TARGETS_DN | 2.36e-04 | 105 | 6 | 2 | M17387 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 4.39e-04 | 751 | 6 | 3 | M5885 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.33e-04 | 158 | 6 | 2 | MM17063 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP | 8.26e-04 | 197 | 6 | 2 | M6278 | |
| Coexpression | GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN | 8.52e-04 | 200 | 6 | 2 | M6548 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP | 8.52e-04 | 200 | 6 | 2 | M9348 | |
| Coexpression | NABA_MATRISOME | 1.09e-03 | 1026 | 6 | 3 | M5889 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-06 | 179 | 6 | 3 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-06 | 180 | 6 | 3 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-06 | 180 | 6 | 3 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.31e-06 | 183 | 6 | 3 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.33e-06 | 184 | 6 | 3 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 10x5'-GI_small-bowel|World / Manually curated celltypes from each tissue | 1.54e-06 | 193 | 6 | 3 | cd89dfe53a114078f06343049685883c8e26508f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-04 | 174 | 6 | 2 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Erythrophagocytic_macrophages|Lung / Manually curated celltypes from each tissue | 2.31e-04 | 178 | 6 | 2 | b63cee443cc1b7416112bf610d7c9d41e4fa37ed | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-04 | 180 | 6 | 2 | 8d9be9cfdf98e5888654a28ab12e5e89f201af00 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 2.60e-04 | 189 | 6 | 2 | 7a260485c2a7c743c14d048e5e480ae0a9b8e32c | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 2.66e-04 | 191 | 6 | 2 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-04 | 192 | 6 | 2 | dcf2d0c2e8868104c4dba410456207f0d947029a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-04 | 192 | 6 | 2 | a22952b885c8a7704a4a9602fa03e4f2c786bf75 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-04 | 193 | 6 | 2 | 930df79b0600f43617052313294be33bcf5631f0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-04 | 193 | 6 | 2 | 32eb026d4317c1499d51294d396dfd5f293f9deb | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-04 | 194 | 6 | 2 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.77e-04 | 195 | 6 | 2 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.77e-04 | 195 | 6 | 2 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 196 | 6 | 2 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.83e-04 | 197 | 6 | 2 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 2.83e-04 | 197 | 6 | 2 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.86e-04 | 198 | 6 | 2 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 198 | 6 | 2 | e3e2233c796d5e9051c8c1b66f70f406f048ed56 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 198 | 6 | 2 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 198 | 6 | 2 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 198 | 6 | 2 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 198 | 6 | 2 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 198 | 6 | 2 | a76366611f3561fc8aca7d62d1f0a0ea2bef7792 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 198 | 6 | 2 | 270cecff42b87b7e03f09dd9f99547b287b4598c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 198 | 6 | 2 | 8b3f4effaaccf8777cde854d5d8a765962f7312b | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.86e-04 | 198 | 6 | 2 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 198 | 6 | 2 | c48b3f026b16d48b8eca9f74dc1e3f3f39a89322 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 198 | 6 | 2 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 198 | 6 | 2 | 686d973483d027a3ffa2ad4430ba6e50f3d1378e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 198 | 6 | 2 | 8fac96132663f54566136ef54b53684d31dfde32 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 198 | 6 | 2 | 8d629492d2199de8e036c19e9dacceb9c9e721a0 | |
| ToppCell | C_01|World / shred on cell type and cluster | 2.86e-04 | 198 | 6 | 2 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.86e-04 | 198 | 6 | 2 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 198 | 6 | 2 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 198 | 6 | 2 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-04 | 199 | 6 | 2 | ab71b312635a2b2c98d71b60a299f44bc80a3587 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-04 | 199 | 6 | 2 | 0181c13379f869be47804cdb11bbdabcd30b9b23 | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-04 | 199 | 6 | 2 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.89e-04 | 199 | 6 | 2 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-04 | 199 | 6 | 2 | 043c65bdf54a1bf0e483fea9ffc042ff5b271764 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-04 | 199 | 6 | 2 | 914f66e2b4af323d09fa2340a39cf8051d00a422 | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.89e-04 | 199 | 6 | 2 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-04 | 199 | 6 | 2 | ee981046217e8759610eb58a670d98f32cd83abc | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-04 | 199 | 6 | 2 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.89e-04 | 199 | 6 | 2 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-04 | 200 | 6 | 2 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-04 | 200 | 6 | 2 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-04 | 200 | 6 | 2 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-04 | 200 | 6 | 2 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 200 | 6 | 2 | 3e13c9a4ba99a7dfbf738b0fb63fb54b4dee5897 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 200 | 6 | 2 | 73bfdf068a8ecbefc1e6afe9686df73658ee042f | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.91e-04 | 200 | 6 | 2 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.91e-04 | 200 | 6 | 2 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| Drug | rioprostil | 4.00e-05 | 32 | 7 | 2 | CID005311413 | |
| Drug | cellobiitol | 5.37e-05 | 37 | 7 | 2 | CID000003871 | |
| Drug | Gastrin tetrapeptide | 9.86e-05 | 50 | 7 | 2 | CID000005415 | |
| Drug | Tn epitope | 1.19e-04 | 55 | 7 | 2 | CID000447272 | |
| Drug | mucic acid | 3.06e-04 | 88 | 7 | 2 | CID000000607 | |
| Drug | Glauber's salt | 3.57e-04 | 95 | 7 | 2 | CID000062649 | |
| Drug | guanidine hydrochloride | 6.57e-04 | 129 | 7 | 2 | CID000005742 | |
| Drug | inulin | 6.98e-04 | 133 | 7 | 2 | CID000024763 | |
| Drug | CsCl | 7.29e-04 | 136 | 7 | 2 | CID000024293 | |
| Drug | heparin pentasaccharide | 8.17e-04 | 144 | 7 | 2 | CID000444410 | |
| Drug | AC1Q6S3U | 9.95e-04 | 159 | 7 | 2 | CID000000689 | |
| Drug | bromide | 2.77e-03 | 267 | 7 | 2 | CID000000259 | |
| Drug | histamine | 1.17e-02 | 560 | 7 | 2 | CID000000774 | |
| Disease | heart rate response to exercise | 3.10e-05 | 43 | 6 | 2 | EFO_0009184 | |
| Disease | cholangiocarcinoma (is_marker_for) | 6.91e-05 | 64 | 6 | 2 | DOID:4947 (is_marker_for) | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 2.05e-04 | 110 | 6 | 2 | EFO_0803335 | |
| Disease | lifestyle measurement | 9.28e-04 | 235 | 6 | 2 | EFO_0010724 | |
| Disease | apolipoprotein A 1 measurement | 1.15e-02 | 848 | 6 | 2 | EFO_0004614 | |
| Disease | creatinine measurement | 1.56e-02 | 995 | 6 | 2 | EFO_0004518 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYTMVSSVIPETSSL | 671 | Q8WXI7 | |
| SPYMDTSSTTQTSII | 4021 | Q8WXI7 | |
| PVTTVTSTYSMTTTE | 166 | Q02505 | |
| NSTTEITYPTTMTET | 721 | Q02505 | |
| ITYPTTMTETSSTAT | 726 | Q02505 | |
| TVTESTTEITYPTTM | 1471 | Q02505 | |
| TTEITYPTTMTETSS | 1476 | Q02505 | |
| SITSTYTVTSMTTTT | 1766 | Q02505 | |
| YIIKTTSESTPESMS | 731 | Q16821 | |
| YSSITVEVPTTSDTE | 151 | Q9NV92 | |
| TSLTYKVDMSTPLTT | 176 | Q685J3 | |
| PVTTVTRTYPMTTTE | 166 | Q9H195 | |
| MSVTTDSTVTTSPYA | 1976 | Q6N021 |